• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

T2 Mapping Identifies Early Anthracycline-Induced Cardiotoxicity in Elderly Patients With Cancer.

作者信息

Martin-Garcia Ana, Diaz-Pelaez Elena, Lopez-Corral Lucia, Sanchez-Pablo Clara, Macias de Plasencia Guillermo, Galan-Arriola Carlos, Sanchez-Gonzalez Javier, Cruz Juan Jesus, Ibanez Borja, Sanchez Pedro L

出版信息

JACC Cardiovasc Imaging. 2020 Jul;13(7):1630-1632. doi: 10.1016/j.jcmg.2020.01.017. Epub 2020 Mar 18.

DOI:10.1016/j.jcmg.2020.01.017
PMID:32199840
Abstract
摘要

相似文献

1
T2 Mapping Identifies Early Anthracycline-Induced Cardiotoxicity in Elderly Patients With Cancer.T2 映射可识别老年癌症患者早期蒽环类药物所致心脏毒性。
JACC Cardiovasc Imaging. 2020 Jul;13(7):1630-1632. doi: 10.1016/j.jcmg.2020.01.017. Epub 2020 Mar 18.
2
Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance.采用T2加权心脏磁共振成像对乳腺癌幸存者蒽环类药物所致心脏毒性进行早期检测
Circ Cardiovasc Imaging. 2019 May;12(5):e008777. doi: 10.1161/CIRCIMAGING.118.008777.
3
[Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity].[心脏肿瘤学：蒽环类药物毒性预防的当前研究进展]
Kardiologiia. 2016 Dec;56(12):72-79.
4
Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.蒽环类药物所致心脏毒性的预防：挑战与机遇。
J Am Coll Cardiol. 2014 Sep 2;64(9):938-45. doi: 10.1016/j.jacc.2014.06.1167.
5
Cardioprotection in cancer therapy: novel insights with anthracyclines.癌症治疗中的心脏保护：蒽环类药物的新见解。
Cardiovasc Res. 2019 Apr 15;115(5):915-921. doi: 10.1093/cvr/cvz023.
6
Managing anthracycline-induced cardiotoxicity: beginning with the end in mind.应对蒽环类药物所致心脏毒性：从结局出发进行管理。
Future Cardiol. 2015 Jul;11(4):363-6. doi: 10.2217/FCA.15.35. Epub 2015 Aug 4.
7
Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.蒽环类药物诱导的心脏毒性的病理生理学及预防策略
Korean J Intern Med. 2016 Jul;31(4):625-33. doi: 10.3904/kjim.2016.017. Epub 2016 Jul 1.
8
Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: A narrative review.肌钙蛋白作为接受蒽环类化疗的乳腺癌患者的心脏毒性标志物：一篇叙述性综述。
Biomed Pharmacother. 2018 Nov;107:989-996. doi: 10.1016/j.biopha.2018.08.035. Epub 2018 Aug 23.
9
Assessment of early anthracycline-induced cardiotoxicity and liver injury with T2 and T2* mapping in rabbit models.应用 T2 和 T2* mapping 技术评估兔模型中早期蒽环类药物诱导的心脏毒性和肝损伤。
Eur Radiol. 2024 Jan;34(1):226-235. doi: 10.1007/s00330-023-10027-1. Epub 2023 Aug 8.
10
Pediatric quality of life in long-term survivors of childhood cancer treated with anthracyclines.接受蒽环类药物治疗的儿童癌症长期幸存者的儿科生活质量。
Pediatr Blood Cancer. 2016 Dec;63(12):2205-2211. doi: 10.1002/pbc.26149. Epub 2016 Jul 21.

引用本文的文献

1
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart.癌症治疗相关心脏功能障碍临床前模型的最新进展：挑战与展望。欧洲心脏病学会心力衰竭协会（HFA）、欧洲心脏病学会心脏肿瘤学委员会以及欧洲心脏病学会心脏细胞生物学工作组的科学声明。
Eur J Heart Fail. 2025 Jun;27(6):1028-1046. doi: 10.1002/ejhf.3636. Epub 2025 Mar 11.
2
Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy.阿托伐他汀与蒽环类药物化疗期间心肌细胞外容量扩张
JACC CardioOncol. 2025 Feb;7(2):125-137. doi: 10.1016/j.jaccao.2024.11.008. Epub 2025 Jan 28.
3
Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop.器官间通讯：心脏保护和神经保护的途径与靶点。第12届哈特心血管研究所研讨会报告。
Basic Res Cardiol. 2025 Apr;120(2):287-299. doi: 10.1007/s00395-024-01094-6. Epub 2024 Dec 16.
4
Cardioprotection strategies for anthracycline cardiotoxicity.针对蒽环类药物心脏毒性的心脏保护策略。
Basic Res Cardiol. 2025 Feb;120(1):71-90. doi: 10.1007/s00395-024-01078-6. Epub 2024 Sep 9.
5
Anthracycline therapy induces an early decline of cardiac contractility in low-risk patients with breast cancer.蒽环类药物治疗会导致低风险乳腺癌患者的心脏收缩力早期下降。
Cardiooncology. 2024 Jul 16;10(1):43. doi: 10.1186/s40959-024-00244-y.
6
Predictive Factors of Therapy-Related Cardiovascular Events in Patients with Lymphoma Receiving Anthracyclines.预测接受蒽环类药物治疗的淋巴瘤患者发生治疗相关心血管事件的因素。
Med Sci (Basel). 2024 Apr 24;12(2):23. doi: 10.3390/medsci12020023.
7
Cardiac magnetic relaxometry versus ejection fraction in anthracycline-related cardiac changes: a systematic review and meta-analysis.心脏磁共振弛豫率与射血分数在蒽环类药物相关心脏改变中的比较：系统评价和荟萃分析。
Open Heart. 2023 Jul;10(2). doi: 10.1136/openhrt-2023-002344.
8
Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.心血管肿瘤学中的心血管影像学：超声心动图和心脏 MRI 在现代心血管肿瘤学中的作用。
Heart Fail Clin. 2022 Jul;18(3):455-478. doi: 10.1016/j.hfc.2022.02.007.
9
T2 mapping in myocardial disease: a comprehensive review.心肌疾病的 T2 映射：全面综述。
J Cardiovasc Magn Reson. 2022 Jun 6;24(1):33. doi: 10.1186/s12968-022-00866-0.
10
The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity.寻找蒽环类药物所致心脏毒性的早期标志物
JACC Basic Transl Sci. 2022 Jan 24;7(1):11-13. doi: 10.1016/j.jacbts.2021.11.010. eCollection 2022 Jan.